The Food and Drug Administration (FDA) recently authorized the initial CRISPR-based gene therapy for sickle cell disease. The new breakthrough enables a potential cure through direct gene correction of faulty sequences. The advancement shows how gene editing continues to transform the direction of personalized healthcare. The present reality surpasses innovation as it exists presently.
CRISPR truly feels like science fiction becoming science fact. The idea that we can now “edit out” a lifelong disease like sickle cell is revolutionary. Hope this opens doors for many other genetic disorders too.
Curious to see how accessibility and affordability will be handled — a cure is powerful, but it should also be reachable.